SLC6A3 and Alzheimer disease: While there was no significant difference observed in the percentage of cells positive for DAT (except between BM-MSC and AD-MSC induced with FGF2 alone), there was a decrease in the cells positive for synaptophysin in the induction protocol where BDNF was also used.